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Summary
Objective: The primary objective of the present study was to establish the degree to which chondrocyte apoptosis occurs in vivo following
intraarticular fractures in humans.
Design: Fracture cartilage specimens were obtained from patients undergoing surgical intervention for fractures of the articular surface of the
proximal tibia. Normal proximal tibia cartilage specimens served as controls. Apoptotic chondrocytes were identified and quantified using
TUNEL analysis.
Results: The percentage of TUNEL positive chondrocytes in the fractured articular cartilage specimens (mean 18.5%, range 1–44%) was
found to be an order of magnitude higher than the percentage observed in control specimens (mean 1.9%, range 0–4%).
Conclusions: The percentage of TUNEL positive chondrocytes following intraarticular fracture is much higher than that reported for chronic
degenerative conditions such as osteoarthritis and rheumatoid arthritis. These data provide strong evidence that chondrocyte apoptosis is
a consequence of intraarticular fracture and suggest that chondrocyte apoptosis may play a particularly significant role in the subsequent
development of post-traumatic arthritis. © 2002 Published by Elsevier Science Ltd on behalf of OsteoArthritis Research Society International
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The development of post-traumatic arthritis following
intraarticular fracture remains a major unsolved clinical
problem. Of particular interest is the possibility that exten-
sive chondrocyte apoptosis occurs following intraarticular
fracture and may contribute to the development of post-
traumatic arthritis. Chondrocyte apoptosis has been
associated with degenerative cartilage diseases such as
osteoarthritis (OA) and rheumatoid arthritis (RA)1–3. The
acutely traumatized joint is an ideal microenvironment for
the occurrence of chondrocyte apoptosis due to the con-
vergence of several known mediators of chondrocyte pro-
grammed cell death, including matrix injury, the influx
of inflammatory cells, the release of proinflammatory
cytokines, the generation of reactive oxygen species, and
the potential for continued joint injury from mechanical
overload. The objective of the present study was to estab-
lish the degree to which chondrocyte apoptosis occurs
in vivo following intraarticular fractures in humans.Received 15 April 2002; accepted 20 June 2002.
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Pieces of cartilage that otherwise would have been
discarded were collected from patients undergoing surgery
for intraarticular fractures of the proximal tibia. For this747study, a single joint surface was selected for analysis based
on preliminary data suggesting that cartilage from different
joint surfaces may respond differently to mechanical injury.
Exclusion criteria were: patient age >60, radiographic evi-
dence of pre-existing joint pathology, or evidence of con-
current joint infection. A total of 15 specimens were
obtained from 12 patients. The median age was 39 (range
21–57); 10 patients were male and two patients were
female. Control samples of proximal tibial articular cartilage
were collected from grossly normal knees at the time of
limb amputation or joint resection as part of limb salvage
surgery, and screened by light microscopy for degenerative
changes. All tissue collection was performed following
procedures approved by the Committee on Human
Research and Institutional Review Board.
Specimens were fixed in 10% buffered formalin, decalci-
fied, dehydrated, and embedded in paraffin for routine
histology. The embedded specimens were sectioned at
5 m thickness. DNA fragmentation analysis for apoptosis
(a.k.a. TUNEL) was performed using the ApopTag Direct
apoptosis detection kit (Oncor, MD). DAPI was used as a
counter stain to label all nuclei. Labeled sections were
examined using fluorescence microscopy with appropriate
filters, and data was recorded using a Zeiss Axiocam digital
camera. ‘Percent positive cells’ was defined as the number
of TUNEL positive cells divided by the number of DAPI
positive cells. Measurements for each specimen were
taken from three near-adjacent sections, and then aver-
aged. Each captured field measured 1.3×1.0 mm, and
included the area of maximal apoptosis. Selected sections
were subjected to a modified TUNEL technique as
described by Aigner and colleagues to minimize non-
specific labeling4. Independent confirmation of chondrocyte
apoptosis was performed on selected specimens using
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phology5 and immunohistochemistry using antiPARP p85
fragment antibody(Promega, WI), a highly specific marker
for apoptosis6. Statistical analysis was performed using
Mann–Whitney test for non-parametric analysis.TUNEL positive chondrocytes was more uniform through-
out the entire section. Modifications to the TUNEL tech-
nique designed to maximize specificity for apoptotic cells4
resulted in a slight decrease in the observed percentage
of positive cells, but this difference was not statistically
significant. We noted good correlation between TUNEL
positive cells and nuclear morphology consistent with
apoptosis including nuclear condensation and blebbing.
Positive staining with anti-PARP p85 provided independent
confirmation of chondrocyte apoptosis.Fig. 1. (a) Percentage of TUNEL positive cells from cartilage specimens retrieved from patients with tibial plateau fractures and from normal
controls (means with S.E.; P<0.0001). (b) Scatter plot of TUNEL positive cells vs time from injury to sample collection. Each data point
represents a single specimen (mean of measurements obtained from three sections).Fig. 2. DAPI staining (left panel) and TUNEL analysis (middle panel) of cartilage retrieved from a 32-year-old patient with an intraarticular
fracture of the proximal tibia. TUNEL identifies cells with DNA fragmentation that is a hallmark of apoptosis. Fracture surface is on the right;
articular surface is at the top. TUNEL analysis of control cartilage is shown in the right panel.Discussion
In spite of limitations inherent in this type of retrieval
study—including a relatively modest number of specimens
and the inability to control the precise location of sampled
tissues—the data provide strong evidence that abundant
chondrocyte apoptosis is a consequence of intraarticular
fracture. These findings are consistent with a recent report
documenting increased levels of apoptosis in biopsies of
human cartilage obtained one to six months after acuteResults
Markedly increased numbers of TUNEL positive
chondrocytes were noted in the fracture specimens com-
pared with normal controls. The mean percentage of
TUNEL positive cells in fracture specimens was 18.5 (stan-
dard deviation 12.4; range 1–44); the mean percentage in
control specimens was 1.9 (standard deviation 1.2; range
1–4) [Fig. 1(a)]. The highest percentage of TUNEL positive
cells was observed in samples collected approximately five
days after injury [Fig. 1(b)]. The distribution of TUNEL
positive cells varied significantly among the different speci-
mens. In a majority of samples, TUNEL positive chondro-
cytes were concentrated at the fracture edge with
extension into the superficial and middle zones of the
cartilage (Fig. 2). In other samples, the distribution of
Osteoarthritis and Cartilage Vol. 10, No. 9 749knee injury7. The signals that mediate chondrocyte apop-
tosis following cartilage injury are not clear. A major
contributing factor may be the loss of pro-survival
signals resulting from extracellular matrix degradation.
Chondrocyte survival is known to be dependent upon intact
matrix, and chondrocyte apoptosis has been linked to
matrix degeneration as measured by Safranin O staining of
proteoglycans1. The relationship between proteoglycan
depletion and apoptosis was not studied in a systematic
fashion in this study; however, we have observed a similar
association in an in vivo rabbit model of acute cartilage
injury (data not shown).
The general increase in the percentage of TUNEL posi-
tive cells over the first five to six days following fracture is
similar to that observed in recent in vitro studies of cartilage
explants subjected to mechanical injury8–9. This delay in
peak apoptosis may represent a window of opportunity for
intervention as suggested by D’Lima and colleagues9.
Recent studies have demonstrated that inhibitors of cas-
pases, key enzymatic mediators of apoptosis, can inhibit
chondrocyte death and maintain chondrocyte functionality
in vitro9–12. Given the potential toxicity of long-term treat-
ment with caspase inhibitors, short-term use following
intraarticular injury may prove to be the optimal application
for these anti-apoptotic agents. Furthermore, the high
levels of chondrocyte apoptosis observed following intra-
articular fracture in humans suggest that interventions
aimed at limiting chondrocyte loss through apoptosis in-
hibition may be particularly effective in the setting of acute
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